First Amendment to Ocuphire Pharma, Inc. 2021 Inducement Plan

Contract Categories: Human Resources › Bonus & Incentive Agreements
Summary

This amendment updates the Ocuphire Pharma, Inc. 2021 Inducement Plan by increasing the total number of shares of common stock available for issuance under the plan to 2,325,258 shares. The change is effective as of November 1, 2023. The amendment modifies the plan in accordance with its existing terms and does not alter any other provisions.

Read More Arrow
EX-10.3 4 ef20013742_ex10-3.htm EXHIBIT 10.3
Exhibit 10.3

FIRST AMENDMENT TO
OCUPHIRE PHARMA, INC.
2021 INDUCEMENT PLAN

The Ocuphire Pharma, Inc. 2021 Inducement Plan (the “Plan”) is hereby amended in the following respects, effective November 1, 2023, in accordance with Section 2(b)(vi) of the Plan.

The first sentence of Section 3(a) of the Plan is deleted in its entirety and replaced with the following sentence:

“Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Awards will not exceed 2,325,258 shares (the “Share Reserve”).”